Skip to main content

ESLICARBAZEPINE ACETATE

NDC 59651-533 · Aurobindo Pharma Limited

Generic nameESLICARBAZEPINE ACETATE
Dosage formTABLET
RouteORAL
Active ingredient(s)ESLICARBAZEPINE ACETATE
Strength200 mg/1
Pharmacologic classCytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]
Marketing categoryANDA

Packages

59651-533-30 — 30 TABLET in 1 BOTTLE (59651-533-30)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

31722-430 — Eslicarbazepine acetate, 31722-431 — Eslicarbazepine acetate, 43598-684 — Eslicarbazepine Acetate, 43598-685 — Eslicarbazepine Acetate, 43598-686 — Eslicarbazepine Acetate, 43598-687 — Eslicarbazepine Acetate, 51407-779 — Eslicarbazepine Acetate, 51407-780 — Eslicarbazepine Acetate, 51407-781 — Eslicarbazepine Acetate, 51407-782 — Eslicarbazepine Acetate, 59651-534 — ESLICARBAZEPINE ACETATE, 59651-535 — ESLICARBAZEPINE ACETATE, 59651-536 — ESLICARBAZEPINE ACETATE, 59746-717 — eslicarbazepine acetate, 59746-718 — eslicarbazepine acetate, 59746-719 — eslicarbazepine acetate, 59746-720 — eslicarbazepine acetate, 60505-4658 — Eslicarbazepine Acetate, 60505-4659 — Eslicarbazepine Acetate, 60505-4660 — Eslicarbazepine Acetate, +19 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.